|
 LOS ANGELES (AP) - For years, Botox-maker Allergan Inc. has been fighting the battle to relieve age-conscious men and women of their forehead wrinkles and crow's feet — without much competition.
But while Botox has been wildly popular with practitioners of cosmetic medicine, the tissue-paralyzing treatment has not helped Irvine-based Allergan capture the growing market for treating wrinkles on the other two thirds of the human face.
That's poised to change with Allergan's pending takeover of Inamed Corp., which makes a line of compounds known as dermal fillers preferred by doctors to diminish the presence of lines and wrinkles on the rest of the face.
|